Vicente de Pablos

750 total citations
14 papers, 371 citations indexed

About

Vicente de Pablos is a scholar working on Neurology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Vicente de Pablos has authored 14 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Neurology, 11 papers in Cellular and Molecular Neuroscience and 5 papers in Neurology. Recurrent topics in Vicente de Pablos's work include Parkinson's Disease Mechanisms and Treatments (12 papers), Nerve injury and regeneration (5 papers) and Neuroinflammation and Neurodegeneration Mechanisms (5 papers). Vicente de Pablos is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (12 papers), Nerve injury and regeneration (5 papers) and Neuroinflammation and Neurodegeneration Mechanisms (5 papers). Vicente de Pablos collaborates with scholars based in Spain, Italy and Brazil. Vicente de Pablos's co-authors include María Trinidad Herrero, Emiliano Fernández‐Villalba, Carlos Barcia, Carmen María Brugarolas Ros, Valentina Annese, Francisco Ros‐Bernal, José Enrique Yuste, Aurora Gómez, María-Angeles Carrillo-de Sauvage and Maria Egle De Stefano and has published in prestigious journals such as Journal of Virology, Scientific Reports and Movement Disorders.

In The Last Decade

Vicente de Pablos

14 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vicente de Pablos Spain 9 180 158 152 85 59 14 371
Isaac Treviño United States 6 195 1.1× 216 1.4× 186 1.2× 121 1.4× 78 1.3× 6 415
Bradford Casey United States 7 122 0.7× 189 1.2× 154 1.0× 134 1.6× 58 1.0× 8 363
Iva Aleksić Serbia 5 184 1.0× 191 1.2× 102 0.7× 62 0.7× 59 1.0× 7 352
Betty Jurek Germany 6 181 1.0× 144 0.9× 76 0.5× 62 0.7× 25 0.4× 6 374
Drew Adler United States 4 205 1.1× 94 0.6× 71 0.5× 146 1.7× 71 1.2× 5 386
Verena May Germany 6 160 0.9× 236 1.5× 149 1.0× 114 1.3× 91 1.5× 6 442
Juliana Rezende Dutra United States 4 208 1.2× 222 1.4× 128 0.8× 68 0.8× 89 1.5× 6 355
Galina Marsh United States 7 100 0.6× 121 0.8× 95 0.6× 152 1.8× 148 2.5× 8 359
Daniel Hinkerohe Germany 9 164 0.9× 33 0.2× 144 0.9× 212 2.5× 65 1.1× 10 452
Elisa Faggiani Italy 5 242 1.3× 49 0.3× 70 0.5× 86 1.0× 77 1.3× 7 392

Countries citing papers authored by Vicente de Pablos

Since Specialization
Citations

This map shows the geographic impact of Vicente de Pablos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vicente de Pablos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vicente de Pablos more than expected).

Fields of papers citing papers by Vicente de Pablos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vicente de Pablos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vicente de Pablos. The network helps show where Vicente de Pablos may publish in the future.

Co-authorship network of co-authors of Vicente de Pablos

This figure shows the co-authorship network connecting the top 25 collaborators of Vicente de Pablos. A scholar is included among the top collaborators of Vicente de Pablos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vicente de Pablos. Vicente de Pablos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Herrero, María Trinidad, José Enrique Yuste, Lorena Cuenca‐Bermejo, et al.. (2023). 7-Nitroindazole reduces L-DOPA-induced dyskinesias in non-human Parkinsonian primate. Open Biology. 13(5). 220370–220370. 3 indexed citations
2.
Cuenca‐Bermejo, Lorena, Pilar Almela, José Enrique Yuste, et al.. (2021). Cardiac tyrosine hydroxylase activation and MB-COMT in dyskinetic monkeys. Scientific Reports. 11(1). 19871–19871. 2 indexed citations
3.
Almela, Pilar, Lorena Cuenca‐Bermejo, José Enrique Yuste, et al.. (2019). Cardiac Noradrenaline Turnover and Heat Shock Protein 27 Phosphorylation in Dyskinetic Monkeys. Movement Disorders. 35(4). 698–703. 7 indexed citations
4.
Annese, Valentina, María Trinidad Herrero, Ana Gómez, et al.. (2014). Metalloproteinase-9 contributes to inflammatory glia activation and nigro-striatal pathway degeneration in both mouse and monkey models of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinsonism. Brain Structure and Function. 220(2). 703–727. 54 indexed citations
5.
Barcia, Carlos, Carmen María Brugarolas Ros, Francisco Ros‐Bernal, et al.. (2013). Persistent phagocytic characteristics of microglia in the substantia nigra of long-term Parkinsonian macaques. Journal of Neuroimmunology. 261(1-2). 60–66. 33 indexed citations
6.
Annese, Valentina, Carlos Barcia, Francisco Ros‐Bernal, et al.. (2012). Evidence of oligodendrogliosis in 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐induced Parkinsonism. Neuropathology and Applied Neurobiology. 39(2). 132–143. 15 indexed citations
7.
Barcia, Carlos, Carmen María Brugarolas Ros, Valentina Annese, et al.. (2012). ROCK/Cdc42-mediated microglial motility and gliapse formation lead to phagocytosis of degenerating dopaminergic neurons in vivo. Scientific Reports. 2(1). 809–809. 122 indexed citations
8.
Barcia, Carlos, Carmen María Brugarolas Ros, Francisco Ros‐Bernal, et al.. (2012). Nigral degeneration correlates with persistent activation of cerebellar Purkinje cells in MPTP-treated monkeys.. PubMed. 27(1). 89–94. 34 indexed citations
9.
Pablos, Vicente de, Carlos Barcia, Silvia Martínez‐Subiela, et al.. (2009). MPTP administration increases plasma levels of acute phase proteins in non-human primates (Macaca fascicularis). Neuroscience Letters. 463(1). 37–39. 8 indexed citations
10.
Barcia, Carlos, Francisco Ros‐Bernal, David Aguado‐Llera, et al.. (2009). Inflammatory Response in Parkinsonism. PubMed. 245–252. 11 indexed citations
11.
Barcia, Carlos, Carmen María Brugarolas Ros, Francisco Ros‐Bernal, et al.. (2009). Increase of Secondary Processes of Microglial and Astroglial Cells After MPTP-Induced Degeneration in Substantia Nigra Pars Compacta of Non Human Primates. PubMed. 253–258. 8 indexed citations
12.
Barcia, Carlos, Aurora Gómez, Vicente de Pablos, et al.. (2008). CD20, CD3, and CD40 Ligand Microclusters Segregate Three-Dimensionally In Vivo at B-Cell-T-Cell Immunological Synapses after Viral Immunity in Primate Brain. Journal of Virology. 82(20). 9978–9993. 15 indexed citations
13.
Barcia, Carlos, Vicente de Pablos, Víctor Bautista‐Hernández, et al.. (2005). Increased plasma levels of TNF-α but not of IL1-β in MPTP-treated monkeys one year after the MPTP administration. Parkinsonism & Related Disorders. 11(7). 435–439. 46 indexed citations
14.
Barcia, Carlos, Vicente de Pablos, Víctor Bautista‐Hernández, et al.. (2004). Measurement of motor disability in MPTP-treated macaques using a telemetry system for estimating circadian motor activity. Journal of Neuroscience Methods. 134(1). 59–64. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026